Clinical trials in A Coruna Galicia – page 22

585 clinical trials in A Coruna Galicia, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

A Coruna Galicia at a glance

585

clinical trials

Research sites3

Quick filters

585 trials in A Coruna Galicia

Open in trial search

Hormone receptor positive HER2 negative breast cancer

Not yet recruiting

Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

InvestigationalNo placebo

Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:Medica Scientia Innovation Research S.L.

Contact Research Centre

Small cell lung cancer

Not yet recruiting

Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

InvestigationalNo placebo

Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:AL8326
Sponsor:Advenchen Pharmaceuticals LLC

Contact Research Centre

Hypercholesterolaemia

Not yet recruiting

Study on the Effects and Safety of MK-0616 for Adults with High Cholesterol

Investigational

Study on the Effects and Safety of MK-0616 for Adults with High Cholesterol

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:MK-0616
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Neoplasm malignant

Not yet recruiting

Study of BLU-451 for Patients with Advanced Cancers Having EGFR Exon20 Insertion Mutations

InvestigationalNo placebo

Study of BLU-451 for Patients with Advanced Cancers Having EGFR Exon20 Insertion Mutations

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:BLU-451
Sponsor:Blueprint Medicines Corp.

Contact Research Centre

Fallopian tube cancer+1

Not yet recruiting

Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Registered drugNo placebo

Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drug

Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Eli Lilly & Co.

Contact Research Centre

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Eli Lilly & Co.

Contact Research Centre

Factor VIII deficiency+1

Not yet recruiting

Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

Registered drugNo placebo

Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efmoroctocog Alfa
Sponsor:Swedish Orphan Biovitrum AB (publ)

Contact Research Centre

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Redasemtide
Sponsor:Shionogi B.V.

Contact Research Centre

Hypoparathyroidism

Not yet recruiting

Study on the Effectiveness and Safety of Eneboparatide in Patients with Chronic Hypoparathyroidism

Registered drug

Study on the Effectiveness and Safety of Eneboparatide in Patients with Chronic Hypoparathyroidism

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Alfacalcidol
Sponsor:Amolyt Pharma

Contact Research Centre

Transitional cell carcinoma

Not yet recruiting

Study Comparing Chemotherapy Before or After Surgery for Patients with Upper Tract Urothelial Carcinoma Using Gemcitabine

Registered drugNo placebo

Study Comparing Chemotherapy Before or After Surgery for Patients with Upper Tract Urothelial Carcinoma Using Gemcitabine

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Gemcitabine
Sponsor:European Uro-Oncology Group Stichting

Contact Research Centre

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Spain

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in A Coruna Galicia

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on atherosclerotic cardiovascular disease prevention are currently underway. These studies aim to evaluate new therapeutic approaches for reducing major adverse cardiovascular events in high-risk patients.

Primary Prevention Studies
Cardiovascular Risk Management
Novel Therapeutic Approaches

The research emphasizes preventive strategies for patients at high risk of developing cardiovascular complications, including heart attacks, strokes, and conditions requiring urgent coronary procedures.

Back to Spain All countries